Global Cell Therapy and Gene Therapy CDMO Market Research Report 2026(Status and Outlook)
Cell and Gene Therapy (CGT for short, excluding broad cell therapies such as unmodified stem cells) is a method of using gene therapy vectors to transduce exogenous therapeutic genes into cells, and then through external Transcription and translation of source genes, a method of changing the original gene expression of cells to treat diseases.
The global Cell Therapy and Gene Therapy CDMO market size was estimated at USD 4390.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 20.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cell Therapy and Gene Therapy CDMO market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cell Therapy and Gene Therapy CDMO market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cell Therapy and Gene Therapy CDMO market.
Global Cell Therapy and Gene Therapy CDMO Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Lonza Pharmaceuticals
Thermo Fisher
catalent
Jubilant LifeSciences
Boehringer Ingelheim
Oxford BioMedica
Charles River
WuXi AppTec
He Yuan Biology
GenScript Biotech
Kanglong Chemical
Porton shares
Sano Biologics
Yunzhou Biology
Market Segmentation (by Type)
Cell Therapy
Gene Therapy
Market Segmentation (by Application)
Clinical Stage Projects
Commercialization Stage Projects
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cell Therapy and Gene Therapy CDMO Market
Overview of the regional outlook of the Cell Therapy and Gene Therapy CDMO Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell Therapy and Gene Therapy CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cell Therapy and Gene Therapy CDMO, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Cell Therapy and Gene Therapy CDMO market size was estimated at USD 4390.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 20.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cell Therapy and Gene Therapy CDMO market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cell Therapy and Gene Therapy CDMO market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cell Therapy and Gene Therapy CDMO market.
Global Cell Therapy and Gene Therapy CDMO Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Lonza Pharmaceuticals
Thermo Fisher
catalent
Jubilant LifeSciences
Boehringer Ingelheim
Oxford BioMedica
Charles River
WuXi AppTec
He Yuan Biology
GenScript Biotech
Kanglong Chemical
Porton shares
Sano Biologics
Yunzhou Biology
Market Segmentation (by Type)
Cell Therapy
Gene Therapy
Market Segmentation (by Application)
Clinical Stage Projects
Commercialization Stage Projects
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cell Therapy and Gene Therapy CDMO Market
Overview of the regional outlook of the Cell Therapy and Gene Therapy CDMO Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell Therapy and Gene Therapy CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cell Therapy and Gene Therapy CDMO, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cell Therapy and Gene Therapy CDMO
1.2 Key Market Segments
1.2.1 Cell Therapy and Gene Therapy CDMO Segment by Type
1.2.2 Cell Therapy and Gene Therapy CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL THERAPY AND GENE THERAPY CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cell Therapy and Gene Therapy CDMO Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Cell Therapy and Gene Therapy CDMO Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL THERAPY AND GENE THERAPY CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cell Therapy and Gene Therapy CDMO Product Life Cycle
3.3 Global Cell Therapy and Gene Therapy CDMO Sales by Manufacturers (2020-2025)
3.4 Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Manufacturers (2020-2025)
3.5 Cell Therapy and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cell Therapy and Gene Therapy CDMO Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cell Therapy and Gene Therapy CDMO Market Competitive Situation and Trends
3.8.1 Cell Therapy and Gene Therapy CDMO Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cell Therapy and Gene Therapy CDMO Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CELL THERAPY AND GENE THERAPY CDMO INDUSTRY CHAIN ANALYSIS
4.1 Cell Therapy and Gene Therapy CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL THERAPY AND GENE THERAPY CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cell Therapy and Gene Therapy CDMO Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cell Therapy and Gene Therapy CDMO Market
5.7 ESG Ratings of Leading Companies
6 CELL THERAPY AND GENE THERAPY CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Type (2020-2025)
6.3 Global Cell Therapy and Gene Therapy CDMO Market Size by Type (2020-2025)
6.4 Global Cell Therapy and Gene Therapy CDMO Price by Type (2020-2025)
7 CELL THERAPY AND GENE THERAPY CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell Therapy and Gene Therapy CDMO Market Sales by Application (2020-2025)
7.3 Global Cell Therapy and Gene Therapy CDMO Market Size (M USD) by Application (2020-2025)
7.4 Global Cell Therapy and Gene Therapy CDMO Sales Growth Rate by Application (2020-2025)
8 CELL THERAPY AND GENE THERAPY CDMO MARKET SALES BY REGION
8.1 Global Cell Therapy and Gene Therapy CDMO Sales by Region
8.1.1 Global Cell Therapy and Gene Therapy CDMO Sales by Region
8.1.2 Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Region
8.2 Global Cell Therapy and Gene Therapy CDMO Market Size by Region
8.2.1 Global Cell Therapy and Gene Therapy CDMO Market Size by Region
8.2.2 Global Cell Therapy and Gene Therapy CDMO Market Size by Region
8.3 North America
8.3.1 North America Cell Therapy and Gene Therapy CDMO Sales by Country
8.3.2 North America Cell Therapy and Gene Therapy CDMO Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cell Therapy and Gene Therapy CDMO Sales by Country
8.4.2 Europe Cell Therapy and Gene Therapy CDMO Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cell Therapy and Gene Therapy CDMO Sales by Region
8.5.2 Asia Pacific Cell Therapy and Gene Therapy CDMO Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cell Therapy and Gene Therapy CDMO Sales by Country
8.6.2 South America Cell Therapy and Gene Therapy CDMO Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cell Therapy and Gene Therapy CDMO Sales by Region
8.7.2 Middle East and Africa Cell Therapy and Gene Therapy CDMO Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CELL THERAPY AND GENE THERAPY CDMO MARKET PRODUCTION BY REGION
9.1 Global Production of Cell Therapy and Gene Therapy CDMO by Region(2020-2025)
9.2 Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Region (2020-2025)
9.3 Global Cell Therapy and Gene Therapy CDMO Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cell Therapy and Gene Therapy CDMO Production
9.4.1 North America Cell Therapy and Gene Therapy CDMO Production Growth Rate (2020-2025)
9.4.2 North America Cell Therapy and Gene Therapy CDMO Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cell Therapy and Gene Therapy CDMO Production
9.5.1 Europe Cell Therapy and Gene Therapy CDMO Production Growth Rate (2020-2025)
9.5.2 Europe Cell Therapy and Gene Therapy CDMO Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cell Therapy and Gene Therapy CDMO Production (2020-2025)
9.6.1 Japan Cell Therapy and Gene Therapy CDMO Production Growth Rate (2020-2025)
9.6.2 Japan Cell Therapy and Gene Therapy CDMO Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cell Therapy and Gene Therapy CDMO Production (2020-2025)
9.7.1 China Cell Therapy and Gene Therapy CDMO Production Growth Rate (2020-2025)
9.7.2 China Cell Therapy and Gene Therapy CDMO Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Lonza Pharmaceuticals
10.1.1 Lonza Pharmaceuticals Basic Information
10.1.2 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product Overview
10.1.3 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product Market Performance
10.1.4 Lonza Pharmaceuticals Business Overview
10.1.5 Lonza Pharmaceuticals SWOT Analysis
10.1.6 Lonza Pharmaceuticals Recent Developments
10.2 Thermo Fisher
10.2.1 Thermo Fisher Basic Information
10.2.2 Thermo Fisher Cell Therapy and Gene Therapy CDMO Product Overview
10.2.3 Thermo Fisher Cell Therapy and Gene Therapy CDMO Product Market Performance
10.2.4 Thermo Fisher Business Overview
10.2.5 Thermo Fisher SWOT Analysis
10.2.6 Thermo Fisher Recent Developments
10.3 catalent
10.3.1 catalent Basic Information
10.3.2 catalent Cell Therapy and Gene Therapy CDMO Product Overview
10.3.3 catalent Cell Therapy and Gene Therapy CDMO Product Market Performance
10.3.4 catalent Business Overview
10.3.5 catalent SWOT Analysis
10.3.6 catalent Recent Developments
10.4 Jubilant LifeSciences
10.4.1 Jubilant LifeSciences Basic Information
10.4.2 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product Overview
10.4.3 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product Market Performance
10.4.4 Jubilant LifeSciences Business Overview
10.4.5 Jubilant LifeSciences Recent Developments
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Basic Information
10.5.2 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product Overview
10.5.3 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product Market Performance
10.5.4 Boehringer Ingelheim Business Overview
10.5.5 Boehringer Ingelheim Recent Developments
10.6 Oxford BioMedica
10.6.1 Oxford BioMedica Basic Information
10.6.2 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product Overview
10.6.3 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product Market Performance
10.6.4 Oxford BioMedica Business Overview
10.6.5 Oxford BioMedica Recent Developments
10.7 Charles River
10.7.1 Charles River Basic Information
10.7.2 Charles River Cell Therapy and Gene Therapy CDMO Product Overview
10.7.3 Charles River Cell Therapy and Gene Therapy CDMO Product Market Performance
10.7.4 Charles River Business Overview
10.7.5 Charles River Recent Developments
10.8 WuXi AppTec
10.8.1 WuXi AppTec Basic Information
10.8.2 WuXi AppTec Cell Therapy and Gene Therapy CDMO Product Overview
10.8.3 WuXi AppTec Cell Therapy and Gene Therapy CDMO Product Market Performance
10.8.4 WuXi AppTec Business Overview
10.8.5 WuXi AppTec Recent Developments
10.9 He Yuan Biology
10.9.1 He Yuan Biology Basic Information
10.9.2 He Yuan Biology Cell Therapy and Gene Therapy CDMO Product Overview
10.9.3 He Yuan Biology Cell Therapy and Gene Therapy CDMO Product Market Performance
10.9.4 He Yuan Biology Business Overview
10.9.5 He Yuan Biology Recent Developments
10.10 GenScript Biotech
10.10.1 GenScript Biotech Basic Information
10.10.2 GenScript Biotech Cell Therapy and Gene Therapy CDMO Product Overview
10.10.3 GenScript Biotech Cell Therapy and Gene Therapy CDMO Product Market Performance
10.10.4 GenScript Biotech Business Overview
10.10.5 GenScript Biotech Recent Developments
10.11 Kanglong Chemical
10.11.1 Kanglong Chemical Basic Information
10.11.2 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product Overview
10.11.3 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product Market Performance
10.11.4 Kanglong Chemical Business Overview
10.11.5 Kanglong Chemical Recent Developments
10.12 Porton shares
10.12.1 Porton shares Basic Information
10.12.2 Porton shares Cell Therapy and Gene Therapy CDMO Product Overview
10.12.3 Porton shares Cell Therapy and Gene Therapy CDMO Product Market Performance
10.12.4 Porton shares Business Overview
10.12.5 Porton shares Recent Developments
10.13 Sano Biologics
10.13.1 Sano Biologics Basic Information
10.13.2 Sano Biologics Cell Therapy and Gene Therapy CDMO Product Overview
10.13.3 Sano Biologics Cell Therapy and Gene Therapy CDMO Product Market Performance
10.13.4 Sano Biologics Business Overview
10.13.5 Sano Biologics Recent Developments
10.14 Yunzhou Biology
10.14.1 Yunzhou Biology Basic Information
10.14.2 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product Overview
10.14.3 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product Market Performance
10.14.4 Yunzhou Biology Business Overview
10.14.5 Yunzhou Biology Recent Developments
11 CELL THERAPY AND GENE THERAPY CDMO MARKET FORECAST BY REGION
11.1 Global Cell Therapy and Gene Therapy CDMO Market Size Forecast
11.2 Global Cell Therapy and Gene Therapy CDMO Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cell Therapy and Gene Therapy CDMO Market Size Forecast by Country
11.2.3 Asia Pacific Cell Therapy and Gene Therapy CDMO Market Size Forecast by Region
11.2.4 South America Cell Therapy and Gene Therapy CDMO Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cell Therapy and Gene Therapy CDMO by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Cell Therapy and Gene Therapy CDMO Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Cell Therapy and Gene Therapy CDMO by Type (2026-2035)
12.1.2 Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Cell Therapy and Gene Therapy CDMO by Type (2026-2035)
12.2 Global Cell Therapy and Gene Therapy CDMO Market Forecast by Application (2026-2035)
12.2.1 Global Cell Therapy and Gene Therapy CDMO Sales (K Units) Forecast by Application
12.2.2 Global Cell Therapy and Gene Therapy CDMO Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cell Therapy and Gene Therapy CDMO
1.2 Key Market Segments
1.2.1 Cell Therapy and Gene Therapy CDMO Segment by Type
1.2.2 Cell Therapy and Gene Therapy CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL THERAPY AND GENE THERAPY CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cell Therapy and Gene Therapy CDMO Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Cell Therapy and Gene Therapy CDMO Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL THERAPY AND GENE THERAPY CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cell Therapy and Gene Therapy CDMO Product Life Cycle
3.3 Global Cell Therapy and Gene Therapy CDMO Sales by Manufacturers (2020-2025)
3.4 Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Manufacturers (2020-2025)
3.5 Cell Therapy and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cell Therapy and Gene Therapy CDMO Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cell Therapy and Gene Therapy CDMO Market Competitive Situation and Trends
3.8.1 Cell Therapy and Gene Therapy CDMO Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cell Therapy and Gene Therapy CDMO Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CELL THERAPY AND GENE THERAPY CDMO INDUSTRY CHAIN ANALYSIS
4.1 Cell Therapy and Gene Therapy CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL THERAPY AND GENE THERAPY CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cell Therapy and Gene Therapy CDMO Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cell Therapy and Gene Therapy CDMO Market
5.7 ESG Ratings of Leading Companies
6 CELL THERAPY AND GENE THERAPY CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Type (2020-2025)
6.3 Global Cell Therapy and Gene Therapy CDMO Market Size by Type (2020-2025)
6.4 Global Cell Therapy and Gene Therapy CDMO Price by Type (2020-2025)
7 CELL THERAPY AND GENE THERAPY CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell Therapy and Gene Therapy CDMO Market Sales by Application (2020-2025)
7.3 Global Cell Therapy and Gene Therapy CDMO Market Size (M USD) by Application (2020-2025)
7.4 Global Cell Therapy and Gene Therapy CDMO Sales Growth Rate by Application (2020-2025)
8 CELL THERAPY AND GENE THERAPY CDMO MARKET SALES BY REGION
8.1 Global Cell Therapy and Gene Therapy CDMO Sales by Region
8.1.1 Global Cell Therapy and Gene Therapy CDMO Sales by Region
8.1.2 Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Region
8.2 Global Cell Therapy and Gene Therapy CDMO Market Size by Region
8.2.1 Global Cell Therapy and Gene Therapy CDMO Market Size by Region
8.2.2 Global Cell Therapy and Gene Therapy CDMO Market Size by Region
8.3 North America
8.3.1 North America Cell Therapy and Gene Therapy CDMO Sales by Country
8.3.2 North America Cell Therapy and Gene Therapy CDMO Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cell Therapy and Gene Therapy CDMO Sales by Country
8.4.2 Europe Cell Therapy and Gene Therapy CDMO Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cell Therapy and Gene Therapy CDMO Sales by Region
8.5.2 Asia Pacific Cell Therapy and Gene Therapy CDMO Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cell Therapy and Gene Therapy CDMO Sales by Country
8.6.2 South America Cell Therapy and Gene Therapy CDMO Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cell Therapy and Gene Therapy CDMO Sales by Region
8.7.2 Middle East and Africa Cell Therapy and Gene Therapy CDMO Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CELL THERAPY AND GENE THERAPY CDMO MARKET PRODUCTION BY REGION
9.1 Global Production of Cell Therapy and Gene Therapy CDMO by Region(2020-2025)
9.2 Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Region (2020-2025)
9.3 Global Cell Therapy and Gene Therapy CDMO Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cell Therapy and Gene Therapy CDMO Production
9.4.1 North America Cell Therapy and Gene Therapy CDMO Production Growth Rate (2020-2025)
9.4.2 North America Cell Therapy and Gene Therapy CDMO Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cell Therapy and Gene Therapy CDMO Production
9.5.1 Europe Cell Therapy and Gene Therapy CDMO Production Growth Rate (2020-2025)
9.5.2 Europe Cell Therapy and Gene Therapy CDMO Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cell Therapy and Gene Therapy CDMO Production (2020-2025)
9.6.1 Japan Cell Therapy and Gene Therapy CDMO Production Growth Rate (2020-2025)
9.6.2 Japan Cell Therapy and Gene Therapy CDMO Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cell Therapy and Gene Therapy CDMO Production (2020-2025)
9.7.1 China Cell Therapy and Gene Therapy CDMO Production Growth Rate (2020-2025)
9.7.2 China Cell Therapy and Gene Therapy CDMO Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Lonza Pharmaceuticals
10.1.1 Lonza Pharmaceuticals Basic Information
10.1.2 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product Overview
10.1.3 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product Market Performance
10.1.4 Lonza Pharmaceuticals Business Overview
10.1.5 Lonza Pharmaceuticals SWOT Analysis
10.1.6 Lonza Pharmaceuticals Recent Developments
10.2 Thermo Fisher
10.2.1 Thermo Fisher Basic Information
10.2.2 Thermo Fisher Cell Therapy and Gene Therapy CDMO Product Overview
10.2.3 Thermo Fisher Cell Therapy and Gene Therapy CDMO Product Market Performance
10.2.4 Thermo Fisher Business Overview
10.2.5 Thermo Fisher SWOT Analysis
10.2.6 Thermo Fisher Recent Developments
10.3 catalent
10.3.1 catalent Basic Information
10.3.2 catalent Cell Therapy and Gene Therapy CDMO Product Overview
10.3.3 catalent Cell Therapy and Gene Therapy CDMO Product Market Performance
10.3.4 catalent Business Overview
10.3.5 catalent SWOT Analysis
10.3.6 catalent Recent Developments
10.4 Jubilant LifeSciences
10.4.1 Jubilant LifeSciences Basic Information
10.4.2 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product Overview
10.4.3 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product Market Performance
10.4.4 Jubilant LifeSciences Business Overview
10.4.5 Jubilant LifeSciences Recent Developments
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Basic Information
10.5.2 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product Overview
10.5.3 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product Market Performance
10.5.4 Boehringer Ingelheim Business Overview
10.5.5 Boehringer Ingelheim Recent Developments
10.6 Oxford BioMedica
10.6.1 Oxford BioMedica Basic Information
10.6.2 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product Overview
10.6.3 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product Market Performance
10.6.4 Oxford BioMedica Business Overview
10.6.5 Oxford BioMedica Recent Developments
10.7 Charles River
10.7.1 Charles River Basic Information
10.7.2 Charles River Cell Therapy and Gene Therapy CDMO Product Overview
10.7.3 Charles River Cell Therapy and Gene Therapy CDMO Product Market Performance
10.7.4 Charles River Business Overview
10.7.5 Charles River Recent Developments
10.8 WuXi AppTec
10.8.1 WuXi AppTec Basic Information
10.8.2 WuXi AppTec Cell Therapy and Gene Therapy CDMO Product Overview
10.8.3 WuXi AppTec Cell Therapy and Gene Therapy CDMO Product Market Performance
10.8.4 WuXi AppTec Business Overview
10.8.5 WuXi AppTec Recent Developments
10.9 He Yuan Biology
10.9.1 He Yuan Biology Basic Information
10.9.2 He Yuan Biology Cell Therapy and Gene Therapy CDMO Product Overview
10.9.3 He Yuan Biology Cell Therapy and Gene Therapy CDMO Product Market Performance
10.9.4 He Yuan Biology Business Overview
10.9.5 He Yuan Biology Recent Developments
10.10 GenScript Biotech
10.10.1 GenScript Biotech Basic Information
10.10.2 GenScript Biotech Cell Therapy and Gene Therapy CDMO Product Overview
10.10.3 GenScript Biotech Cell Therapy and Gene Therapy CDMO Product Market Performance
10.10.4 GenScript Biotech Business Overview
10.10.5 GenScript Biotech Recent Developments
10.11 Kanglong Chemical
10.11.1 Kanglong Chemical Basic Information
10.11.2 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product Overview
10.11.3 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product Market Performance
10.11.4 Kanglong Chemical Business Overview
10.11.5 Kanglong Chemical Recent Developments
10.12 Porton shares
10.12.1 Porton shares Basic Information
10.12.2 Porton shares Cell Therapy and Gene Therapy CDMO Product Overview
10.12.3 Porton shares Cell Therapy and Gene Therapy CDMO Product Market Performance
10.12.4 Porton shares Business Overview
10.12.5 Porton shares Recent Developments
10.13 Sano Biologics
10.13.1 Sano Biologics Basic Information
10.13.2 Sano Biologics Cell Therapy and Gene Therapy CDMO Product Overview
10.13.3 Sano Biologics Cell Therapy and Gene Therapy CDMO Product Market Performance
10.13.4 Sano Biologics Business Overview
10.13.5 Sano Biologics Recent Developments
10.14 Yunzhou Biology
10.14.1 Yunzhou Biology Basic Information
10.14.2 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product Overview
10.14.3 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product Market Performance
10.14.4 Yunzhou Biology Business Overview
10.14.5 Yunzhou Biology Recent Developments
11 CELL THERAPY AND GENE THERAPY CDMO MARKET FORECAST BY REGION
11.1 Global Cell Therapy and Gene Therapy CDMO Market Size Forecast
11.2 Global Cell Therapy and Gene Therapy CDMO Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cell Therapy and Gene Therapy CDMO Market Size Forecast by Country
11.2.3 Asia Pacific Cell Therapy and Gene Therapy CDMO Market Size Forecast by Region
11.2.4 South America Cell Therapy and Gene Therapy CDMO Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cell Therapy and Gene Therapy CDMO by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Cell Therapy and Gene Therapy CDMO Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Cell Therapy and Gene Therapy CDMO by Type (2026-2035)
12.1.2 Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Cell Therapy and Gene Therapy CDMO by Type (2026-2035)
12.2 Global Cell Therapy and Gene Therapy CDMO Market Forecast by Application (2026-2035)
12.2.1 Global Cell Therapy and Gene Therapy CDMO Sales (K Units) Forecast by Application
12.2.2 Global Cell Therapy and Gene Therapy CDMO Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cell Therapy and Gene Therapy CDMO Market Size by Type (M USD)
Table 4. Global Cell Therapy and Gene Therapy CDMO Market Size by Application
Table 5. Cell Therapy and Gene Therapy CDMO Market Size Comparison by Region (M USD)
Table 6. Global Cell Therapy and Gene Therapy CDMO Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Cell Therapy and Gene Therapy CDMO Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Cell Therapy and Gene Therapy CDMO Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy and Gene Therapy CDMO as of 2025)
Table 11. Global Market Cell Therapy and Gene Therapy CDMO Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Cell Therapy and Gene Therapy CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell Therapy and Gene Therapy CDMO Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Cell Therapy and Gene Therapy CDMO Sales by Type (K Units)
Table 27. Global Cell Therapy and Gene Therapy CDMO Market Size by Type (M USD)
Table 28. Global Cell Therapy and Gene Therapy CDMO Sales (K Units) by Type (2020-2025)
Table 29. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Type (2020-2025)
Table 30. Global Cell Therapy and Gene Therapy CDMO Market Size (M USD) by Type (2020-2025)
Table 31. Global Cell Therapy and Gene Therapy CDMO Market Share by Type (2020-2025)
Table 32. Global Cell Therapy and Gene Therapy CDMO Price (USD/Unit) by Type (2020-2025)
Table 33. Global Cell Therapy and Gene Therapy CDMO Sales (K Units) by Application
Table 34. Global Cell Therapy and Gene Therapy CDMO Market Size by Application
Table 35. Global Cell Therapy and Gene Therapy CDMO Sales by Application (2020-2025) & (K Units)
Table 36. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Application (2020-2025)
Table 37. Global Cell Therapy and Gene Therapy CDMO Market Size by Application (2020-2025) & (M USD)
Table 38. Global Cell Therapy and Gene Therapy CDMO Market Share by Application (2020-2025)
Table 39. Global Cell Therapy and Gene Therapy CDMO Sales Growth Rate by Application (2020-2025)
Table 40. Global Cell Therapy and Gene Therapy CDMO Sales by Region (2020-2025) & (K Units)
Table 41. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Region (2020-2025)
Table 42. Global Cell Therapy and Gene Therapy CDMO Market Size by Region (2020-2025) & (M USD)
Table 43. Global Cell Therapy and Gene Therapy CDMO Market Size by Region (2020-2025)
Table 44. North America Cell Therapy and Gene Therapy CDMO Sales by Country (2020-2025) & (K Units)
Table 45. North America Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Cell Therapy and Gene Therapy CDMO Sales by Country (2020-2025) & (K Units)
Table 47. Europe Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Cell Therapy and Gene Therapy CDMO Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Cell Therapy and Gene Therapy CDMO Market Size by Region (2020-2025) & (M USD)
Table 50. South America Cell Therapy and Gene Therapy CDMO Sales by Country (2020-2025) & (K Units)
Table 51. South America Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Cell Therapy and Gene Therapy CDMO Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Cell Therapy and Gene Therapy CDMO Market Size by Region (2020-2025) & (M USD)
Table 54. Global Cell Therapy and Gene Therapy CDMO Production (K Units) by Region(2020-2025)
Table 55. Global Cell Therapy and Gene Therapy CDMO Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Region (2020-2025)
Table 57. Global Cell Therapy and Gene Therapy CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Cell Therapy and Gene Therapy CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Cell Therapy and Gene Therapy CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Cell Therapy and Gene Therapy CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Cell Therapy and Gene Therapy CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Lonza Pharmaceuticals Basic Information
Table 63. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product Overview
Table 64. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Lonza Pharmaceuticals Business Overview
Table 66. Lonza Pharmaceuticals SWOT Analysis
Table 67. Lonza Pharmaceuticals Recent Developments
Table 68. Thermo Fisher Basic Information
Table 69. Thermo Fisher Cell Therapy and Gene Therapy CDMO Product Overview
Table 70. Thermo Fisher Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Thermo Fisher Business Overview
Table 72. Thermo Fisher SWOT Analysis
Table 73. Thermo Fisher Recent Developments
Table 74. catalent Basic Information
Table 75. catalent Cell Therapy and Gene Therapy CDMO Product Overview
Table 76. catalent Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. catalent Business Overview
Table 78. catalent SWOT Analysis
Table 79. catalent Recent Developments
Table 80. Jubilant LifeSciences Basic Information
Table 81. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product Overview
Table 82. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Jubilant LifeSciences Business Overview
Table 84. Jubilant LifeSciences Recent Developments
Table 85. Boehringer Ingelheim Basic Information
Table 86. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product Overview
Table 87. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Boehringer Ingelheim Business Overview
Table 89. Boehringer Ingelheim Recent Developments
Table 90. Oxford BioMedica Basic Information
Table 91. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product Overview
Table 92. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Oxford BioMedica Business Overview
Table 94. Oxford BioMedica Recent Developments
Table 95. Charles River Basic Information
Table 96. Charles River Cell Therapy and Gene Therapy CDMO Product Overview
Table 97. Charles River Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Charles River Business Overview
Table 99. Charles River Recent Developments
Table 100. WuXi AppTec Basic Information
Table 101. WuXi AppTec Cell Therapy and Gene Therapy CDMO Product Overview
Table 102. WuXi AppTec Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. WuXi AppTec Business Overview
Table 104. WuXi AppTec Recent Developments
Table 105. He Yuan Biology Basic Information
Table 106. He Yuan Biology Cell Therapy and Gene Therapy CDMO Product Overview
Table 107. He Yuan Biology Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. He Yuan Biology Business Overview
Table 109. He Yuan Biology Recent Developments
Table 110. GenScript Biotech Basic Information
Table 111. GenScript Biotech Cell Therapy and Gene Therapy CDMO Product Overview
Table 112. GenScript Biotech Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. GenScript Biotech Business Overview
Table 114. GenScript Biotech Recent Developments
Table 115. Kanglong Chemical Basic Information
Table 116. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product Overview
Table 117. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Kanglong Chemical Business Overview
Table 119. Kanglong Chemical Recent Developments
Table 120. Porton shares Basic Information
Table 121. Porton shares Cell Therapy and Gene Therapy CDMO Product Overview
Table 122. Porton shares Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Porton shares Business Overview
Table 124. Porton shares Recent Developments
Table 125. Sano Biologics Basic Information
Table 126. Sano Biologics Cell Therapy and Gene Therapy CDMO Product Overview
Table 127. Sano Biologics Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Sano Biologics Business Overview
Table 129. Sano Biologics Recent Developments
Table 130. Yunzhou Biology Basic Information
Table 131. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product Overview
Table 132. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Yunzhou Biology Business Overview
Table 134. Yunzhou Biology Recent Developments
Table 135. Global Cell Therapy and Gene Therapy CDMO Sales Forecast by Region (2026-2035) & (K Units)
Table 136. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Cell Therapy and Gene Therapy CDMO Sales Forecast by Country (2026-2035) & (K Units)
Table 138. North America Cell Therapy and Gene Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Cell Therapy and Gene Therapy CDMO Sales Forecast by Country (2026-2035) & (K Units)
Table 140. Europe Cell Therapy and Gene Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Cell Therapy and Gene Therapy CDMO Sales Forecast by Region (2026-2035) & (K Units)
Table 142. Asia Pacific Cell Therapy and Gene Therapy CDMO Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Cell Therapy and Gene Therapy CDMO Sales Forecast by Country (2026-2035) & (K Units)
Table 144. South America Cell Therapy and Gene Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Cell Therapy and Gene Therapy CDMO Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Cell Therapy and Gene Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Cell Therapy and Gene Therapy CDMO Sales Forecast by Type (2026-2035) & (K Units)
Table 148. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Cell Therapy and Gene Therapy CDMO Price Forecast by Type (2026-2035) & (USD/Unit)
Table 150. Global Cell Therapy and Gene Therapy CDMO Sales (K Units) Forecast by Application (2026-2035)
Table 151. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cell Therapy and Gene Therapy CDMO Market Size by Type (M USD)
Table 4. Global Cell Therapy and Gene Therapy CDMO Market Size by Application
Table 5. Cell Therapy and Gene Therapy CDMO Market Size Comparison by Region (M USD)
Table 6. Global Cell Therapy and Gene Therapy CDMO Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Cell Therapy and Gene Therapy CDMO Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Cell Therapy and Gene Therapy CDMO Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy and Gene Therapy CDMO as of 2025)
Table 11. Global Market Cell Therapy and Gene Therapy CDMO Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Cell Therapy and Gene Therapy CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell Therapy and Gene Therapy CDMO Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Cell Therapy and Gene Therapy CDMO Sales by Type (K Units)
Table 27. Global Cell Therapy and Gene Therapy CDMO Market Size by Type (M USD)
Table 28. Global Cell Therapy and Gene Therapy CDMO Sales (K Units) by Type (2020-2025)
Table 29. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Type (2020-2025)
Table 30. Global Cell Therapy and Gene Therapy CDMO Market Size (M USD) by Type (2020-2025)
Table 31. Global Cell Therapy and Gene Therapy CDMO Market Share by Type (2020-2025)
Table 32. Global Cell Therapy and Gene Therapy CDMO Price (USD/Unit) by Type (2020-2025)
Table 33. Global Cell Therapy and Gene Therapy CDMO Sales (K Units) by Application
Table 34. Global Cell Therapy and Gene Therapy CDMO Market Size by Application
Table 35. Global Cell Therapy and Gene Therapy CDMO Sales by Application (2020-2025) & (K Units)
Table 36. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Application (2020-2025)
Table 37. Global Cell Therapy and Gene Therapy CDMO Market Size by Application (2020-2025) & (M USD)
Table 38. Global Cell Therapy and Gene Therapy CDMO Market Share by Application (2020-2025)
Table 39. Global Cell Therapy and Gene Therapy CDMO Sales Growth Rate by Application (2020-2025)
Table 40. Global Cell Therapy and Gene Therapy CDMO Sales by Region (2020-2025) & (K Units)
Table 41. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Region (2020-2025)
Table 42. Global Cell Therapy and Gene Therapy CDMO Market Size by Region (2020-2025) & (M USD)
Table 43. Global Cell Therapy and Gene Therapy CDMO Market Size by Region (2020-2025)
Table 44. North America Cell Therapy and Gene Therapy CDMO Sales by Country (2020-2025) & (K Units)
Table 45. North America Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Cell Therapy and Gene Therapy CDMO Sales by Country (2020-2025) & (K Units)
Table 47. Europe Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Cell Therapy and Gene Therapy CDMO Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Cell Therapy and Gene Therapy CDMO Market Size by Region (2020-2025) & (M USD)
Table 50. South America Cell Therapy and Gene Therapy CDMO Sales by Country (2020-2025) & (K Units)
Table 51. South America Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Cell Therapy and Gene Therapy CDMO Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Cell Therapy and Gene Therapy CDMO Market Size by Region (2020-2025) & (M USD)
Table 54. Global Cell Therapy and Gene Therapy CDMO Production (K Units) by Region(2020-2025)
Table 55. Global Cell Therapy and Gene Therapy CDMO Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Region (2020-2025)
Table 57. Global Cell Therapy and Gene Therapy CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Cell Therapy and Gene Therapy CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Cell Therapy and Gene Therapy CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Cell Therapy and Gene Therapy CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Cell Therapy and Gene Therapy CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Lonza Pharmaceuticals Basic Information
Table 63. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product Overview
Table 64. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Lonza Pharmaceuticals Business Overview
Table 66. Lonza Pharmaceuticals SWOT Analysis
Table 67. Lonza Pharmaceuticals Recent Developments
Table 68. Thermo Fisher Basic Information
Table 69. Thermo Fisher Cell Therapy and Gene Therapy CDMO Product Overview
Table 70. Thermo Fisher Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Thermo Fisher Business Overview
Table 72. Thermo Fisher SWOT Analysis
Table 73. Thermo Fisher Recent Developments
Table 74. catalent Basic Information
Table 75. catalent Cell Therapy and Gene Therapy CDMO Product Overview
Table 76. catalent Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. catalent Business Overview
Table 78. catalent SWOT Analysis
Table 79. catalent Recent Developments
Table 80. Jubilant LifeSciences Basic Information
Table 81. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product Overview
Table 82. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Jubilant LifeSciences Business Overview
Table 84. Jubilant LifeSciences Recent Developments
Table 85. Boehringer Ingelheim Basic Information
Table 86. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product Overview
Table 87. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Boehringer Ingelheim Business Overview
Table 89. Boehringer Ingelheim Recent Developments
Table 90. Oxford BioMedica Basic Information
Table 91. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product Overview
Table 92. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Oxford BioMedica Business Overview
Table 94. Oxford BioMedica Recent Developments
Table 95. Charles River Basic Information
Table 96. Charles River Cell Therapy and Gene Therapy CDMO Product Overview
Table 97. Charles River Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Charles River Business Overview
Table 99. Charles River Recent Developments
Table 100. WuXi AppTec Basic Information
Table 101. WuXi AppTec Cell Therapy and Gene Therapy CDMO Product Overview
Table 102. WuXi AppTec Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. WuXi AppTec Business Overview
Table 104. WuXi AppTec Recent Developments
Table 105. He Yuan Biology Basic Information
Table 106. He Yuan Biology Cell Therapy and Gene Therapy CDMO Product Overview
Table 107. He Yuan Biology Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. He Yuan Biology Business Overview
Table 109. He Yuan Biology Recent Developments
Table 110. GenScript Biotech Basic Information
Table 111. GenScript Biotech Cell Therapy and Gene Therapy CDMO Product Overview
Table 112. GenScript Biotech Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. GenScript Biotech Business Overview
Table 114. GenScript Biotech Recent Developments
Table 115. Kanglong Chemical Basic Information
Table 116. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product Overview
Table 117. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Kanglong Chemical Business Overview
Table 119. Kanglong Chemical Recent Developments
Table 120. Porton shares Basic Information
Table 121. Porton shares Cell Therapy and Gene Therapy CDMO Product Overview
Table 122. Porton shares Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Porton shares Business Overview
Table 124. Porton shares Recent Developments
Table 125. Sano Biologics Basic Information
Table 126. Sano Biologics Cell Therapy and Gene Therapy CDMO Product Overview
Table 127. Sano Biologics Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Sano Biologics Business Overview
Table 129. Sano Biologics Recent Developments
Table 130. Yunzhou Biology Basic Information
Table 131. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product Overview
Table 132. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Yunzhou Biology Business Overview
Table 134. Yunzhou Biology Recent Developments
Table 135. Global Cell Therapy and Gene Therapy CDMO Sales Forecast by Region (2026-2035) & (K Units)
Table 136. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Cell Therapy and Gene Therapy CDMO Sales Forecast by Country (2026-2035) & (K Units)
Table 138. North America Cell Therapy and Gene Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Cell Therapy and Gene Therapy CDMO Sales Forecast by Country (2026-2035) & (K Units)
Table 140. Europe Cell Therapy and Gene Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Cell Therapy and Gene Therapy CDMO Sales Forecast by Region (2026-2035) & (K Units)
Table 142. Asia Pacific Cell Therapy and Gene Therapy CDMO Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Cell Therapy and Gene Therapy CDMO Sales Forecast by Country (2026-2035) & (K Units)
Table 144. South America Cell Therapy and Gene Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Cell Therapy and Gene Therapy CDMO Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Cell Therapy and Gene Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Cell Therapy and Gene Therapy CDMO Sales Forecast by Type (2026-2035) & (K Units)
Table 148. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Cell Therapy and Gene Therapy CDMO Price Forecast by Type (2026-2035) & (USD/Unit)
Table 150. Global Cell Therapy and Gene Therapy CDMO Sales (K Units) Forecast by Application (2026-2035)
Table 151. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cell Therapy and Gene Therapy CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell Therapy and Gene Therapy CDMO Market Size (M USD), 2025-2035
Figure 5. Global Cell Therapy and Gene Therapy CDMO Market Size (M USD) (2020-2035)
Figure 6. Global Cell Therapy and Gene Therapy CDMO Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell Therapy and Gene Therapy CDMO Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cell Therapy and Gene Therapy CDMO Product Life Cycle
Figure 13. Cell Therapy and Gene Therapy CDMO Sales Share by Manufacturers in 2025
Figure 14. Global Cell Therapy and Gene Therapy CDMO Revenue Share by Manufacturers in 2025
Figure 15. Cell Therapy and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Cell Therapy and Gene Therapy CDMO Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cell Therapy and Gene Therapy CDMO Revenue in 2025
Figure 18. Industry Chain Map of Cell Therapy and Gene Therapy CDMO
Figure 19. Global Cell Therapy and Gene Therapy CDMO Market PEST Analysis
Figure 20. Global Cell Therapy and Gene Therapy CDMO Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cell Therapy and Gene Therapy CDMO Market Share by Type
Figure 27. Sales Market Share of Cell Therapy and Gene Therapy CDMO by Type (2020-2025)
Figure 28. Sales Market Share of Cell Therapy and Gene Therapy CDMO by Type in 2025
Figure 29. Market Share of Cell Therapy and Gene Therapy CDMO by Type (2020-2025)
Figure 30. Market Share of Cell Therapy and Gene Therapy CDMO by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cell Therapy and Gene Therapy CDMO Market Share by Application
Figure 33. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Application (2020-2025)
Figure 34. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Application in 2025
Figure 35. Global Cell Therapy and Gene Therapy CDMO Market Share by Application (2020-2025)
Figure 36. Global Cell Therapy and Gene Therapy CDMO Market Share by Application in 2025
Figure 37. Global Cell Therapy and Gene Therapy CDMO Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Region (2020-2025)
Figure 39. Global Cell Therapy and Gene Therapy CDMO Market Size by Region (2020-2025)
Figure 40. North America Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cell Therapy and Gene Therapy CDMO Sales Market Share by Country in 2024
Figure 43. North America Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cell Therapy and Gene Therapy CDMO Market Size by Country in 2024
Figure 45. U.S. Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cell Therapy and Gene Therapy CDMO Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cell Therapy and Gene Therapy CDMO Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cell Therapy and Gene Therapy CDMO Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cell Therapy and Gene Therapy CDMO Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cell Therapy and Gene Therapy CDMO Sales Market Share by Country in 2024
Figure 53. Europe Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cell Therapy and Gene Therapy CDMO Market Size by Country in 2024
Figure 55. Germany Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cell Therapy and Gene Therapy CDMO Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cell Therapy and Gene Therapy CDMO Market Size by Region in 2024
Figure 68. China Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (K Units)
Figure 79. South America Cell Therapy and Gene Therapy CDMO Sales Market Share by Country in 2024
Figure 80. South America Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (M USD)
Figure 81. South America Cell Therapy and Gene Therapy CDMO Market Size by Country in 2024
Figure 82. Brazil Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cell Therapy and Gene Therapy CDMO Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cell Therapy and Gene Therapy CDMO Market Size by Region in 2024
Figure 92. Saudi Arabia Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cell Therapy and Gene Therapy CDMO Production Market Share by Region (2020-2025)
Figure 103. North America Cell Therapy and Gene Therapy CDMO Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cell Therapy and Gene Therapy CDMO Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cell Therapy and Gene Therapy CDMO Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cell Therapy and Gene Therapy CDMO Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cell Therapy and Gene Therapy CDMO Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Cell Therapy and Gene Therapy CDMO Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Cell Therapy and Gene Therapy CDMO Market Share Forecast by Type (2026-2035)
Figure 111. Global Cell Therapy and Gene Therapy CDMO Sales Forecast by Application (2026-2035)
Figure 112. Global Cell Therapy and Gene Therapy CDMO Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Cell Therapy and Gene Therapy CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell Therapy and Gene Therapy CDMO Market Size (M USD), 2025-2035
Figure 5. Global Cell Therapy and Gene Therapy CDMO Market Size (M USD) (2020-2035)
Figure 6. Global Cell Therapy and Gene Therapy CDMO Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell Therapy and Gene Therapy CDMO Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cell Therapy and Gene Therapy CDMO Product Life Cycle
Figure 13. Cell Therapy and Gene Therapy CDMO Sales Share by Manufacturers in 2025
Figure 14. Global Cell Therapy and Gene Therapy CDMO Revenue Share by Manufacturers in 2025
Figure 15. Cell Therapy and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Cell Therapy and Gene Therapy CDMO Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cell Therapy and Gene Therapy CDMO Revenue in 2025
Figure 18. Industry Chain Map of Cell Therapy and Gene Therapy CDMO
Figure 19. Global Cell Therapy and Gene Therapy CDMO Market PEST Analysis
Figure 20. Global Cell Therapy and Gene Therapy CDMO Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cell Therapy and Gene Therapy CDMO Market Share by Type
Figure 27. Sales Market Share of Cell Therapy and Gene Therapy CDMO by Type (2020-2025)
Figure 28. Sales Market Share of Cell Therapy and Gene Therapy CDMO by Type in 2025
Figure 29. Market Share of Cell Therapy and Gene Therapy CDMO by Type (2020-2025)
Figure 30. Market Share of Cell Therapy and Gene Therapy CDMO by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cell Therapy and Gene Therapy CDMO Market Share by Application
Figure 33. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Application (2020-2025)
Figure 34. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Application in 2025
Figure 35. Global Cell Therapy and Gene Therapy CDMO Market Share by Application (2020-2025)
Figure 36. Global Cell Therapy and Gene Therapy CDMO Market Share by Application in 2025
Figure 37. Global Cell Therapy and Gene Therapy CDMO Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cell Therapy and Gene Therapy CDMO Sales Market Share by Region (2020-2025)
Figure 39. Global Cell Therapy and Gene Therapy CDMO Market Size by Region (2020-2025)
Figure 40. North America Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cell Therapy and Gene Therapy CDMO Sales Market Share by Country in 2024
Figure 43. North America Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cell Therapy and Gene Therapy CDMO Market Size by Country in 2024
Figure 45. U.S. Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cell Therapy and Gene Therapy CDMO Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cell Therapy and Gene Therapy CDMO Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cell Therapy and Gene Therapy CDMO Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cell Therapy and Gene Therapy CDMO Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cell Therapy and Gene Therapy CDMO Sales Market Share by Country in 2024
Figure 53. Europe Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cell Therapy and Gene Therapy CDMO Market Size by Country in 2024
Figure 55. Germany Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cell Therapy and Gene Therapy CDMO Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cell Therapy and Gene Therapy CDMO Market Size by Region in 2024
Figure 68. China Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (K Units)
Figure 79. South America Cell Therapy and Gene Therapy CDMO Sales Market Share by Country in 2024
Figure 80. South America Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (M USD)
Figure 81. South America Cell Therapy and Gene Therapy CDMO Market Size by Country in 2024
Figure 82. Brazil Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cell Therapy and Gene Therapy CDMO Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cell Therapy and Gene Therapy CDMO Market Size by Region in 2024
Figure 92. Saudi Arabia Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cell Therapy and Gene Therapy CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cell Therapy and Gene Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cell Therapy and Gene Therapy CDMO Production Market Share by Region (2020-2025)
Figure 103. North America Cell Therapy and Gene Therapy CDMO Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cell Therapy and Gene Therapy CDMO Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cell Therapy and Gene Therapy CDMO Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cell Therapy and Gene Therapy CDMO Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cell Therapy and Gene Therapy CDMO Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Cell Therapy and Gene Therapy CDMO Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Cell Therapy and Gene Therapy CDMO Market Share Forecast by Type (2026-2035)
Figure 111. Global Cell Therapy and Gene Therapy CDMO Sales Forecast by Application (2026-2035)
Figure 112. Global Cell Therapy and Gene Therapy CDMO Market Share Forecast by Application (2026-2035)
